JPS6241664A - 人工透析装置の製造方法 - Google Patents
人工透析装置の製造方法Info
- Publication number
- JPS6241664A JPS6241664A JP18048185A JP18048185A JPS6241664A JP S6241664 A JPS6241664 A JP S6241664A JP 18048185 A JP18048185 A JP 18048185A JP 18048185 A JP18048185 A JP 18048185A JP S6241664 A JPS6241664 A JP S6241664A
- Authority
- JP
- Japan
- Prior art keywords
- hot air
- artificial
- artificial dialysis
- manufacturing
- hollow fiber
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 21
- 238000000502 dialysis Methods 0.000 claims description 64
- 239000012510 hollow fiber Substances 0.000 claims description 36
- 238000000034 method Methods 0.000 claims description 22
- 239000004627 regenerated cellulose Substances 0.000 claims description 9
- 238000009987 spinning Methods 0.000 claims description 5
- QKSIFUGZHOUETI-UHFFFAOYSA-N copper;azane Chemical compound N.N.N.N.[Cu+2] QKSIFUGZHOUETI-UHFFFAOYSA-N 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 239000008280 blood Substances 0.000 description 12
- 210000004369 blood Anatomy 0.000 description 12
- 230000008929 regeneration Effects 0.000 description 7
- 238000011069 regeneration method Methods 0.000 description 7
- 230000001954 sterilising effect Effects 0.000 description 7
- 238000004659 sterilization and disinfection Methods 0.000 description 7
- 239000012528 membrane Substances 0.000 description 6
- 239000000243 solution Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229920001202 Inulin Polymers 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 3
- 229940029339 inulin Drugs 0.000 description 3
- 238000002834 transmittance Methods 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000011265 semifinished product Substances 0.000 description 2
- 238000007711 solidification Methods 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- -1 Claire J Substances 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 241000270708 Testudinidae Species 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000001112 coagulating effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 238000001631 haemodialysis Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000000322 hemodialysis Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- External Artificial Organs (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18048185A JPS6241664A (ja) | 1985-08-19 | 1985-08-19 | 人工透析装置の製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP18048185A JPS6241664A (ja) | 1985-08-19 | 1985-08-19 | 人工透析装置の製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6241664A true JPS6241664A (ja) | 1987-02-23 |
| JPH0121986B2 JPH0121986B2 (enrdf_load_stackoverflow) | 1989-04-24 |
Family
ID=16083976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP18048185A Granted JPS6241664A (ja) | 1985-08-19 | 1985-08-19 | 人工透析装置の製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS6241664A (enrdf_load_stackoverflow) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58118546A (ja) * | 1982-01-08 | 1983-07-14 | Kawaken Fine Chem Co Ltd | 塩酸ジサイクロミンの製造方法 |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60180482A (ja) * | 1984-02-24 | 1985-09-14 | Fuji Xerox Co Ltd | モ−タ用速度制御装置 |
| JPS61146306A (ja) * | 1984-12-20 | 1986-07-04 | Terumo Corp | 透析用中空繊維の製造方法 |
-
1985
- 1985-08-19 JP JP18048185A patent/JPS6241664A/ja active Granted
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS60180482A (ja) * | 1984-02-24 | 1985-09-14 | Fuji Xerox Co Ltd | モ−タ用速度制御装置 |
| JPS61146306A (ja) * | 1984-12-20 | 1986-07-04 | Terumo Corp | 透析用中空繊維の製造方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58118546A (ja) * | 1982-01-08 | 1983-07-14 | Kawaken Fine Chem Co Ltd | 塩酸ジサイクロミンの製造方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0121986B2 (enrdf_load_stackoverflow) | 1989-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5711330B2 (ja) | 一部が蛋白質に結合した物質を取除く装置 | |
| JP5694298B2 (ja) | 改良された性能を有する膜の調製方法 | |
| JPH01104271A (ja) | 膜型人工肺 | |
| JPS6241664A (ja) | 人工透析装置の製造方法 | |
| JPH06165819A (ja) | 血液浄化用中空糸膜 | |
| Luttinger et al. | Improved hemodialysis membranes for the artificial kidney | |
| JP4843988B2 (ja) | ポリスルホン系中空糸膜型血液浄化器 | |
| JPH0245062A (ja) | 血液濃縮器用中空糸膜 | |
| JP4129393B2 (ja) | 湿潤半透膜を含む血液または血漿の体外処理装置およびその製造方法 | |
| JPH0970431A (ja) | ポリスルホン系中空糸型人工腎臓の製造方法および人工腎臓 | |
| JP4003982B2 (ja) | ポリスルホン系選択透過性分離膜 | |
| JPH08168524A (ja) | 血液透析器の作製方法 | |
| JPS6213022B2 (enrdf_load_stackoverflow) | ||
| JP2000210544A (ja) | 半透膜の製造方法 | |
| JPS6241665A (ja) | 人工透析装置の製造方法 | |
| JP3413985B2 (ja) | 選択分離膜およびそれを用いた血液処理装置 | |
| JPS6247367A (ja) | 血液濃縮器 | |
| JPS596663B2 (ja) | 多段「ろ」過・再吸収型人工腎臓 | |
| JPH029418A (ja) | 非発熱性溶液の製造方法 | |
| JPS5930427B2 (ja) | ホロ−ファイバ型人工腎臓の洗浄方法および装置 | |
| JPH10174850A (ja) | 中空繊維膜の処理方法 | |
| JPH0265B2 (enrdf_load_stackoverflow) | ||
| JPS6148375A (ja) | 改良した血液浄化膜及びその製造法 | |
| JPS6328625B2 (enrdf_load_stackoverflow) | ||
| Sweeney | Mass transfer during dialysis |